4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-043119
Sinha Vikas sold 2,635 shares at an average $3.44 ($9,077)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-19 | Sale : show line 1 in the form 10b5-1 | −1,198 | $3.56 | $4,267 | 1,185,654 | D |
| 2023-07-20 | Sale : show line 2 in the form 10b5-1 | −1,437 | $3.35 | $4,810 | 1,184,217 | D |
| Open-market sales · 2,635 sh · avg $3.44 · $9,077 | ||||||
Loading xslF345X05/doc4.xml…